Cite
HARVARD Citation
Faissner, S. et al. (2022). Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination. Therapeutic advances in neurological disorders. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Faissner, S. et al. (2022). Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination. Therapeutic advances in neurological disorders. p. . [Online].